NEW YORK – As the COVID-19 pandemic continues to stress healthcare systems across the US and world, clinical labs and diagnostic firms have raced to ramp up SARS-CoV-2 test volumes.
But while demand for SARS-CoV-2 has soared, volume for non-COVID-19 testing has plummeted as patients are putting off elective procedures and routine doctor's visits.
This week, Quest Diagnostics filed a form 8-K in which it noted that during the last two weeks of March the company's test volumes, inclusive of COVID-19 tests, declined by more than 40 percent.